|
|
||||||||
The Journal of Immunology, Vol 143, Issue 6 1943-1947, Copyright © 1989 by American Association of Immunologists
ARTICLES |
LS Zalman, MA Brothers and HJ Muller-Eberhard
Research Institute of Scripps Clinic, Department of Immunology, La Jolla, CA 92037.
A soluble form of homologous restriction factor (HRF-U) was isolated from normal human urine. With respect to m.w. (65,000) and immunoblotting characteristics, it resembled membrane HRF (HRF-M) that had been isolated from human E membranes. The protein exhibited limited cross-reactivity with the channel-forming proteins of C and cytotoxic lymphocytes. It inhibited reactive lysis of E by human C5b-9. Inhibition occurred at the attachment stage of C5b-7 to target cells, rather than at the C8 or C9 stage of membrane attack complex assembly which is inhibited by HRF-M. In this respect, HRF-U acts analogously to S protein of serum, but no immunochemical relationship between these two proteins was detected. HRF-U might be derived from the soluble HRF detected in cytoplasmic granules of killer lymphocytes.
This article has been cited by other articles:
![]() |
L.-B. Yang, R. Li, S. Meri, J. Rogers, and Y. Shen Deficiency of Complement Defense Protein CD59 May Contribute to Neurodegeneration in Alzheimer's Disease J. Neurosci., October 15, 2000; 20(20): 7505 - 7509. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Acosta, J. Hettinga, R. Fluckiger, N. Krumrei, A. Goldfine, L. Angarita, and J. Halperin Molecular basis for a link between complement and the vascular complications of diabetes PNAS, May 9, 2000; 97(10): 5450 - 5455. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |